为您找到"
300633
"相关结果约100,000,000个
Get the latest SonoScape Medical Corp (300633) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Find the latest SonoScape Medical Corp. (300633.SZ) stock quote, history, news and other vital information to help you with your stock trading and investing.
300633 | Complete Sonoscape Medical Corp. A stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
300633 is trading within a range we consider fairly valued. Price ¥35.78. Oct 31, 2024. Fair Value ¥43.11. Oct 31, 2024. Uncertainty High. 1-Star Price ¥53.27. 5-Star Price ...
Ticker Symbol 300633. Full Company Profile. Financial Performance. In 2023, SonoScape Medical's revenue was 2.12 billion, an increase of 20.29% compared to the previous year's 1.76 billion. Earnings were 454.44 million, an increase of 22.88%. Financial Statements. News. There is no news available yet. Sections. Stocks; IPOs; ETFs;
Get SonoScape Medical Corp (300633.SZ) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments
Stock analysis for Sonoscape Medical Corp (300633:Shenzhen) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
Track SONOSCAPE MEDICAL CORP. (300633) price, historical values, financial information, price forecast, and insights to empower your investing journey | MSN Money
Sonoscape Medical Corp is a company engaged in research, development, production and sales of medical diagnostic and therapeutic equipment. The Company's main products are medical ultrasound diagnostic equipment, such as color Doppler ultrasound diagnostic equipment and B-type ultrasound diagnostic equipment, medical electronic endoscope equipment and consumables, as well as blood analyzers.
View the latest Sonoscape Medical Corp. A (300633) stock price, news, historical charts, analyst ratings and financial information from WSJ.